DaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care

​DaVita and medical device company Medtronic launched their new venture, Mozarc Medical, to develop new kidney care technologies with a specific focus on at-home treatments. Announced nearly a year ago, the company is co-owned by Medtronic and DaVita, each with equal…

Read MoreDaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care

Chemed To Report First-Quarter 2023 Earnings April 26, Related Conference Call To Be Held On April 27

Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2023, on Wednesday, April 26, 2023, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast…

Read MoreChemed To Report First-Quarter 2023 Earnings April 26, Related Conference Call To Be Held On April 27

Masimo Announces FDA Clearance of the Rad-G® with Temperature 

 Masimo (NASDAQ: MASI) today announced that the Rad-G® with Temperature has received FDA 510(k) clearance. Rad-G with Temperature is a rugged, versatile, handheld monitor that provides clinically proven SET® pulse oximetry, respiration rate from the pleth (RRp®), and other important parameters alongside non-contact infrared…

Read MoreMasimo Announces FDA Clearance of the Rad-G® with Temperature 

Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System 

 Masimo (NASDAQ: MASI) today announced that Masimo Opioid Halo™, an opioid overdose prevention and alert system, has been granted a De Novo by the FDA – making it the first and only FDA-cleared monitoring solution for detecting opioid-induced respiratory depression, the leading cause…

Read MoreMasimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System